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SNc neurons recorded in vivo exhibit both pacemaker-like and burst firing patterns (Grace and Bunney, 1984a; Grace and Bunney, 1984b; Tepper et al., 1995) . The finding that SNc neurons recorded in brain slice preparations only exhibit pacemaker like activity has highlighted the importance of afferent inputs in determining the firing pattern of these cells. Anatomical and electrophysiological evidence exists for a direct excitatory projection from the subthalamic nucleus (STN) to the dopaminergic neurons in the SNc (Smith et al., 1990; Smith and Grace, 1992; Iribe et al., 1999 ) that may in part modulate SNc bursting (Smith and Grace, 1992) . This glutamatergic input has been the focus of much attention based on the findings that the STN is overactive in Parkinson's disease (PD) and the fact that glutamate is believed to play a role in the continued degeneration of the SNc dopamine neurons in this disorder (Rodriguez et al., 1998) . However, relatively little work has been focused on the modulatory control of these excitatory inputs.
The metabotropic glutamate receptors (mGluRs) are a class of G-protein coupled receptors that play a variety of neuromodulatory roles in the central nervous system. To date, eight mGluR subtypes have been cloned (for review see (Conn and Pin, 1997) ).
The mGluRs are classified into 3 groups based on sequence homology, agonist and antagonist pharmacology, and coupling to signal transduction pathways in expression systems. Group I (mGluR1 and mGluR5) mGluRs are preferentially expressed in postsynaptic region were they modulate cell excitability. Group II (mGluR2 and mGluR3) and group III (mGluR4, mGluR6, mGluR7 and mGluR8) mGluRs are presynaptically localized and modulate the release of neurotransmitter. Based on the localization in the basal ganglia motor loop, and the functional roles that have been JPET #80481 5 revealed to date, the group III mGluRs, and mGluR4 in particular hold promise for the design of novel palliative treatments for PD (Marino et al., 2003a) .
We previously have shown that presynaptically localized mGluR4 modulates inhibitory transmission at the striatopallidal synapse, a critical synapse in the indirect pathway of the BG motor system (Valenti et al., 2003) . Furthermore, when studied in both acute and chronic behavioral models of PD, activation of mGluR4 produces a dramatic reversal of motor impairment suggesting mGluR4 may provide a potential target for the palliative treatment of PD (Valenti et al., 2003) . Recently, Wigmore and Lacey (Wigmore and Lacey, 1998) have shown that activation of group III mGluRs inhibits excitatory transmission onto midbrain dopamine neurons. Recent developments in selective pharmacological tools (Thomas et al., 2001; Flor et al., 2002; Marino et al., 2003b ) and the availability of knockout mice make it possible to determine with a high degree of certainty which group III mGluR mediates a particular physiological effect.
Based on the potential role of excitatory inputs to the SNc in determining the normal physiology of these cells, as well as the neurodegeneration associated with PD, we set out to pharmacologically characterize this group III mGluR-mediated modulation of transmission.
All recordings were done using HEKA EPC9 patch clamp amplifiers (HEKA Elektronik, Lambrecht/Pfalz, Germany). Excitatory postsynaptic currents (EPSCs) were evoked by electrical stimulation, in the presence of blockers of GABA A (25 µ M Bicuculline methobromide), and GABA B (100 nM CPG 55845) receptors. Bipolar tungsten stimulation electrodes were placed either locally in the SNc ~ 100 µm rostral to the recording site or in the STN. No difference was observed between these 2 groups and the data were combined. EPSCs were evoked from a holding potential of -70 mV by single pulses that ranged from 3-15 V, 200-400 µ sec, delivered once every 30-60 seconds. Monosynaptic EPSCs for failure analysis were stimulated locally through a patch pipette filled with ACSF. These parameters were varied in order to optimize EPSC amplitude and stability.
The SNc was recognized as a cell-dense region dorsal to the SNr in slices All compounds were typically made in a 1000X stock and diluted into the ACSF immediately before use. L-AP4 and (S)-3,4-DCPG were made daily; all other compounds were aliquoted and stored at -20 o C. Compounds were applied to the bath using a three way stopcock. Agonists were always applied for 10 minutes in order to achieve a plateau concentration, while antagonists were applied 5 min prior to agonists and maintained in the bath during agonist application.
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Results

Characterization of the Excitatory Transmission in DA neurons of the SNc.
To test the hypothesis that activation of group III mGluRs modulates transmission at the subthalamo-nigral synapse, we employed whole cell patch clamp recording from dopaminergic neurons in the rat SNc. Consistent with previous reports (Richards et al., 1997), we observed a homogeneous population of neurons with distinct electrophysiological properties including low frequency spike firing, large afterhyperpolarizations, and a prominent time dependent inward rectification produced by the injection of hyperpolarizing currents ( Figure 1A ).
Excitatory postsynaptic currents (EPSCs) were evoked as described in the methodology section. SNc dopaminergic neurons receive glutamatergic projections from the STN as well as a mix of glutamatergic and cholinergic inputs from the pedunculopontine nucleus (Lavoie and Parent, 1994; Charara et al., 1996) . We attempted to favor the glutamatergic inputs from the STN by stimulating rostral to the recording site or within the STN. Single shock electrical stimulation elicited a fast inward current, showing a short and constant latency that attained peak amplitude within approximately 10 msec ( Figure 1B ). The glutamatergic nature of these EPSCs was confirmed by bath application of the AMPA/kainate-selective antagonist, CNQX (20 µM). CNQX produced a complete block of the synaptic response (predrug amplitude: -260.94 ± 56.37 pA, mean + SEM; 20 µ M CNQX amplitude: -19.98 ± 5.14 pA, mean + SEM; n=5 p<0.05, paired ttest) (Fig 1B-D) suggesting that under these conditions these EPSCs are glutamatergic and predominantly due to activation of AMPA or kainate receptors.
This article has not been copyedited and formatted. The final version may differ from this version. Application of the highly selective group III mGluR agonist L-AP4 (Bushell et al., 1995) produced a significant inhibition of the evoked EPSCs ( Figure 2A ) that reversed as the compound washed out of the bath ( Figure 2B ). The response to L-AP4 was dosedependent ( Figure 2C ) with L-AP4 producing a maximal effect of 61.85 ± 2.82 % inhibition at 3 µ M (predrug amplitude: -204.2 ± 34.31 pA, mean + SEM; 3 µ M L-AP4 amplitude: -82.73 ± 19.35 pA, mean ± SEM; n= 7; p<0.05, paired t-test). L-AP4 exhibits potencies at recombinant rat group III mGluRs of 0.2-1 µ M at mGluR4, 0.6-0.9 µ M at mGluR6, 160-1300 µ M at mGluR7, and 0.7-0.9 µ M at mGluR8 (Schoepp et al., 1999) .
Since mGluR7 is only activated by high concentration of L-AP4 and mGluR6 is not expressed at high levels in the brain (Nakajima et al., 1993) , this effect is consistent with an action at either mGluR4 or mGluR8.
L-AP4 Inhibits Transmission by a Presynaptic Mechanism
Immunocytochemical studies have not detected significant levels of mGluR4 or 8 in the SNc, however in situ hybridization studies have reported low to moderate levels of mGluR4 and 8 expression in both the SNc, and the STN (Testa et al., 1994; Messenger et transmission in the SNc by a pre-or postsynaptic mechanism. We first attempted to study the effect of L-AP4 on paired-pulse facilitation. In these studies, we observed a trend towards an increase in paired-pulse ratio in 3 out of 4 cells; however, a high degree of variability in the baseline paired-pulse ratio prohibited an accurate quantitative analysis of these data. We next attempted an analysis of tetrodotoxin-resistant miniature EPSCs, however the extremely low frequency of miniature EPSCs in this region made these studies impossible. Therefore, we employed an analysis of the effects of L-AP4 on failure of monosynaptic EPSCs (Malinow and Tsien, 1990). As described in the methods section, focal electrical stimuli were employed to evoke single fiber monosynaptic EPSCs that had a measurable failure rate ( Figure 3A , 3B) (event probability: 0.79 ± 0.02, n=4).
In contrast to the evokes EPSCs described above which are produced by the synchronized release of transmitter from many synapses, these events are monosynaptic. Thus, alterations in failure rate reflect changes in presynaptic release probability while alterations in amplitude reflect changes in postsynaptic receptor function. Application of excluded from the analysis (predrug event probability: 0.80 ± 0.03, L-AP4 event probability: 0.18 ± 0.1; n=3; p<0.05, paired t-test). When the mean amplitude of events from these three cells was compared with the pre-drug amplitude, no significant effect was observed ( Figure 3D ) (predrug amplitude: -21.0 ± 3.1 pA, mean + SEM; 3 µ M L-AP4 amplitude: -14.8 ± 1.2 pA, mean + SEM; n=3; p>0.1, paired t-test). This increase in failure rate without effect on mean amplitude is consistent with a presynaptic site of action (Malinow and Tsien, 1990) suggesting that L-AP4 decreases excitatory transmission through a presynaptic mechanism of action.
Pharmacology of the L-AP4 Mediated Inhibition of Excitatory Transmission in the Rat SNc
As discussed above, the different potency of L-AP4 at group III receptors suggests that the group III mGluR-mediated inhibition of excitatory transmission in the SNc is consistent with mGluR4 or mGluR8. Since mRNA for both mGluR4 and mGluR8
are expressed in the STN, the likely source of the glutamatergic afferents stimulated in these studies, it is possible that either receptor mediates this effect. We employed available pharmacological tools to attempt to distinguish between these two receptors.
CPPG, a group III mGluR-preferring antagonist (Toms et al., 1996) . Therefore PHCCC represents a selective and novel tool for studying the physiology of mGluR4. We employed PHCCC to confirm the hypothesis that mGluR4 modulates excitatory transmission in SNc. We choose a submaximal 300 nM dose of L-AP4 based on our dose-response study. Application of 300 nM L-AP4 produces a small, yet significant reduction in excitatory transmission (predrug amplitude: -164.4 + 32.2 pA, mean + SEM; 300 nM L-AP4 amplitude: -120.85 + 24.57 pA, mean + SEM; n= 9; p< 0.05, paired t-test). Application of the vehicle 1% DMSO (data not shown) or 30 µM PHCCC alone had no effect on the subthalamo-nigral transmission ( Figure 5C ).
However, when co-applied with 300 nM L-AP4, 30 µM PHCCC produced a significant potentiation of the L-AP4-induced inhibition of the excitatory transmission (predrug This article has not been copyedited and formatted. The final version may differ from this version. Figure 5A -C). Taken together with the potency of L-AP4, and the lack of effect of (S)-3,4-DCPG, these data suggest that the L-AP4 modulation of synaptic transmission at the rat STNSNc synapse is mediated by an activation of mGluR4.
Group III mGluR-Mediate Modulation of Transmission in mGluR4 knockout mice.
Our pharmacological studies suggest that mGluR4 modulates glutamatergic transmission in the SNc. In the attempt to provide further confirmation, we examined the group III mGluR-mediated modulation of excitatory transmission in wild type and Based on the strength of our pharmacological data in the rat, the finding that both L-AP4 and (S)-3,4-DCPG reduce excitatory transmission in the mGluR4 knockouts suggests several possible explanations. First, since we found it necessary to perform these studies in younger mice, the possibility exists that the observed difference is due to a developmental regulation of mGluR8. We therefore tested for the effect of (S)-3,4-DCPG in younger (p7-12) rats. These studies failed to find a significant effect of (S)-3,4-DCPG on EPSC amplitude (predrug amplitude: -77.2 ± 10.7 pA, mean + SEM; 300 nM of (S)-3,4-DCPG amplitude: -60.6 ± 7.0 pA, mean + SEM; n= 5; p>0.05 paired t-test) suggesting that the difference between rat and mouse is not due to a difference in developmental expression of mGluR8. It is also possible that a species difference exists between rats and mice such that mGluR8 alone, or both mGluR4 and mGluR8 modulate excitatory transmission in the mouse SNc. Finally, it is possible that the knockout of To distinguish between these hypotheses, we performed a set of pharmacological studies in wild type mice. We first employed the mGluR8 selective agonist (S)-3,4-DCPG and found that activation of mGluR8 decreases evoked EPSCs amplitude in the SNc. As shown in figure 7E , 300 nM (S)-3,4-DCPG produced a significant reduction in EPSC indicating that a species difference exist between rat and mouse. However, the fact that activation of mGluR8 inhibits transmission at this synapse does not exclude the possibility that mGluR4 could also play a modulatory role in the mouse SNc. Therefore we employed the mGluR4 potentiator PHCCC in order to determine the role of mGluR4 in this effect. 
Discussion
In this study we employed whole cell patch clamp recording methods to investigate the pharmacology of group III mGluR modulation of excitatory transmission in the SNc. We found that in the rat, L-AP4-induced inhibition of transmission is mediated through a presynaptic mechanism by a receptor with a pharmacological profile consistent with mGluR4. Interestingly, when we attempted to confirm this finding using knockout mice, we discovered an apparent species difference. In the mouse both immunoreactivity is observed at high levels in the globus pallidus, where it has been demonstrated to exist on presynaptic terminals that originate from the striatum (Bradley et al., 1999) . In addition, there is a significant mGluR4-positive staining observed in the substantia nigra pars reticulata (Bradley et al., 1999; Corti, et al., 2002) . To date there has not been an immunocytochemical study that has reported the distribution of mGluR8 within the basal ganglia. However, in situ hybridization studies have found significant expression of both mGluR4 and mGluR8 in neurons of the rat STN (Testa et al., 1994; Messenger et al., 2002) .
This article has not been copyedited and formatted. The final version may differ from this version. , 1999) . This high affinity specific binding is very likely due to the presence of mGluR8. Therefore, it is possible that both mGluR4 and mGluR8 protein is appropriately localized in the mouse to mediate the effects observed in the current studies. Future immunocytochemical studies will be necessary to confirm this hypothesis and to determine if mGluR8 is also present in the rat SNr.
This article has not been copyedited and formatted. The final version may differ from this version. (Hubert and Smith, 2004) . While it is not currently known, it remains possible that the group III mGluRs are developmentally regulated in the basal ganglia. Our finding that there is no difference in the effect of (S)-3,4-DCPG in rats between 7 and 20 days postnatal suggests that there is not a gross developmental switch between mGluR8 and mGluR4, however, further anatomical studies are needed to better characterize changes in the expression of these receptors during development.
We previously have suggested that activation of mGluR4 may provide a novel palliative intervention for the treatment of PD (Valenti, et al., 2003) . From the stand point of neurodegeneration associated with PD, the finding that mGluR4 activation also depresses glutamatergic transmission in the SNc has interesting implication for this therapeutic strategy. The etiology of Parkinsonian neurodegeneration is complex and appears to involve a variety of factors including mitochondrial dysfunction and oxidative stress (Beal, 2000; Zhang et al., 2000) . In addition, an indirect excitotoxic hypothesis has been proposed to explain in part the degeneration of dopamine neurons in PD (Albin and Greenamyre, 1992) . According to this hypothesis, an inhibition of normal mitochondrial function leads to an energy deficit and subsequent inability of neurons to maintain a normal resting potential (Erecinska and Dagani, 1990) . The resulting depolarization leads to a relief of the magnesium block of the NMDA receptors, and a state in which normal levels of glutamate become toxic (Novelli et al., 1988) . According to the current Consistent with the observation in slices from rats, activation of group III mGluRs produces an inhibition that reaches a maximum at low micromolar concentrations. This article has not been copyedited and formatted. The final version may differ from this version.
